Tandem Interest Income from 2010 to 2026

TNDM Stock

USD 20.66 0.77 3.87%

Tandem Diabetes Interest Income yearly trend continues to be very stable with very little volatility. Interest Income is likely to grow to about 21.7 M this year. Interest Income is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. View All Fundamentals

Interest Income

First Reported

2019-03-31

Previous Quarter

4.2 M

Current Value

2.5 M

Quarterly Volatility

2.9 M

Covid

Interest Hikes

Check Tandem Diabetes financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tandem Diabetes' main balance sheet or income statement drivers, such as Depreciation And Amortization of 172.6 K, Interest Expense of 6.4 M or Selling General Administrative of 470.7 M, as well as many indicators such as Price To Sales Ratio of 2.74, Dividend Yield of 0.0 or PTB Ratio of 5.14. Tandem financial statements analysis is a perfect complement when working with Tandem Diabetes Valuation or Volatility modules.

Build AI portfolio with Tandem Stock

Check out the analysis of Tandem Diabetes Correlation against competitors.

Evaluating Tandem Diabetes's Interest Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Tandem Diabetes Care's fundamental strength.

Latest Tandem Diabetes' Interest Income Growth Pattern

Below is the plot of the Interest Income of Tandem Diabetes Care over the last few years. It is income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments. Tandem Diabetes' Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tandem Diabetes' overall financial position and show how it may be relating to other accounts over time.

Interest Income

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Interest Income

Timeline

Tandem Interest Income Regression Statistics

	Arithmetic Mean	6,897,618
	Geometric Mean	3,290,822
	Coefficient Of Variation	117.99
	Mean Deviation	6,550,474
	Median	3,404,000
	Standard Deviation	8,138,361
	Sample Variance	66.2T
	Range	22.6M
	R-Value	0.70
	Mean Square Error	36T
	R-Squared	0.49
	Significance	0
	Slope	1,128,422
	Total Sum of Squares	1059.7T

Tandem Interest Income History

	2026	21.7 M
	2025	20.7 M
	2024	18 M
	2023	22.9 M
	2022	6.1 M
	2021	674 K
	2020	1.6 M

Other Fundumenentals of Tandem Diabetes Care

Net Interest Income

Tandem Diabetes Interest Income component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Intangible Assets	Long Term Debt	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.85	0.93	-0.89	0.9	0.99	0.97	0.96	0.99	0.22	0.81	0.98	0.66	0.17	0.95	0.98	0.94	0.9	0.61	0.13	0.96	0.95	0.92
Total Stockholder Equity	0.85		0.61	-0.76	0.68	0.84	0.9	0.69	0.89	-0.11	0.91	0.79	0.58	0.43	0.8	0.85	0.82	0.9	0.58	-0.02	0.91	0.93	0.68
Net Debt	0.93	0.61		-0.84	0.91	0.93	0.85	0.98	0.89	0.47	0.63	0.94	0.64	-0.03	0.88	0.9	0.85	0.79	0.56	0.24	0.85	0.81	0.94
Retained Earnings	-0.89	-0.76	-0.84		-0.87	-0.91	-0.82	-0.86	-0.87	-0.37	-0.88	-0.93	-0.66	0.08	-0.94	-0.86	-0.94	-0.91	-0.76	-0.33	-0.83	-0.8	-0.82
Accounts Payable	0.9	0.68	0.91	-0.87		0.9	0.81	0.92	0.87	0.46	0.7	0.94	0.7	-0.09	0.85	0.84	0.84	0.79	0.6	0.32	0.82	0.8	0.86
Net Receivables	0.99	0.84	0.93	-0.91	0.9		0.96	0.96	0.99	0.25	0.83	0.98	0.63	0.13	0.97	0.98	0.97	0.92	0.67	0.17	0.95	0.94	0.92
Short Term Investments	0.97	0.9	0.85	-0.82	0.81	0.96		0.89	0.98	0.08	0.82	0.92	0.63	0.37	0.91	0.97	0.92	0.9	0.59	0.07	0.98	0.99	0.85
Total Liab	0.96	0.69	0.98	-0.86	0.92	0.96	0.89		0.94	0.36	0.68	0.97	0.65	0.02	0.91	0.94	0.89	0.83	0.56	0.18	0.89	0.86	0.95
Total Current Assets	0.99	0.89	0.89	-0.87	0.87	0.99	0.98	0.94		0.16	0.83	0.97	0.65	0.25	0.94	0.98	0.94	0.91	0.6	0.11	0.98	0.97	0.89
Short Term Debt	0.22	-0.11	0.47	-0.37	0.46	0.25	0.08	0.36	0.16		0.05	0.33	0.01	-0.48	0.24	0.11	0.2	0.09	0.3	0.78	0.08	0.02	0.36
Common Stock	0.81	0.91	0.63	-0.88	0.7	0.83	0.82	0.68	0.83	0.05		0.81	0.58	0.13	0.86	0.81	0.88	0.93	0.63	0.11	0.83	0.82	0.71
Property Plant Equipment	0.98	0.79	0.94	-0.93	0.94	0.98	0.92	0.97	0.97	0.33	0.81		0.67	0.06	0.95	0.96	0.94	0.9	0.65	0.22	0.92	0.9	0.93
Current Deferred Revenue	0.66	0.58	0.64	-0.66	0.7	0.63	0.63	0.65	0.65	0.01	0.58	0.67		0.07	0.61	0.64	0.63	0.68	0.4	0.07	0.66	0.67	0.58
Intangible Assets	0.17	0.43	-0.03	0.08	-0.09	0.13	0.37	0.02	0.25	-0.48	0.13	0.06	0.07		0.01	0.21	0.05	0.19	-0.01	-0.23	0.35	0.42	-0.01
Long Term Debt	0.95	0.8	0.88	-0.94	0.85	0.97	0.91	0.91	0.94	0.24	0.86	0.95	0.61	0.01		0.94	1.0	0.92	0.71	0.22	0.9	0.88	0.88
Net Tangible Assets	0.98	0.85	0.9	-0.86	0.84	0.98	0.97	0.94	0.98	0.11	0.81	0.96	0.64	0.21	0.94		0.94	0.91	0.57	0.0	0.96	0.95	0.91
Long Term Debt Total	0.94	0.82	0.85	-0.94	0.84	0.97	0.92	0.89	0.94	0.2	0.88	0.94	0.63	0.05	1.0	0.94		0.93	0.72	0.22	0.9	0.9	0.86
Capital Surpluse	0.9	0.9	0.79	-0.91	0.79	0.92	0.9	0.83	0.91	0.09	0.93	0.9	0.68	0.19	0.92	0.91	0.93		0.73	0.11	0.95	0.93	0.84
Deferred Long Term Liab	0.61	0.58	0.56	-0.76	0.6	0.67	0.59	0.56	0.6	0.3	0.63	0.65	0.4	-0.01	0.71	0.57	0.72	0.73		0.43	0.62	0.6	0.59
Short Long Term Debt	0.13	-0.02	0.24	-0.33	0.32	0.17	0.07	0.18	0.11	0.78	0.11	0.22	0.07	-0.23	0.22	0.0	0.22	0.11	0.43		0.05	0.05	0.13
Net Invested Capital	0.96	0.91	0.85	-0.83	0.82	0.95	0.98	0.89	0.98	0.08	0.83	0.92	0.66	0.35	0.9	0.96	0.9	0.95	0.62	0.05		0.99	0.87
Net Working Capital	0.95	0.93	0.81	-0.8	0.8	0.94	0.99	0.86	0.97	0.02	0.82	0.9	0.67	0.42	0.88	0.95	0.9	0.93	0.6	0.05	0.99		0.82
Capital Stock	0.92	0.68	0.94	-0.82	0.86	0.92	0.85	0.95	0.89	0.36	0.71	0.93	0.58	-0.01	0.88	0.91	0.86	0.84	0.59	0.13	0.87	0.82

Click cells to compare fundamentals

About Tandem Diabetes Financial Statements

Tandem Diabetes investors utilize fundamental indicators, such as Interest Income, to predict how Tandem Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Interest Income	20.7 M	21.7 M
Net Interest Income	12.2 M	12.8 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

When determining whether Tandem Diabetes Care is a strong investment it is important to analyze Tandem Diabetes' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tandem Diabetes' future performance. For an informed investment choice regarding Tandem Stock, refer to the following important reports:

How To Invest In Tandem

Details

Is Tandem Stock a good investment?

Details

What is Tandem Diabetes' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Tandem Diabetes Correlation against competitors.

You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Will Health Care Equipment & Supplies sector continue expanding? Could Tandem diversify its offerings? Factors like these will boost the valuation of Tandem Diabetes. If investors know Tandem will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Tandem Diabetes data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.

Quarterly Earnings Growth

(0.37)

Earnings Share

(3.03)

Revenue Per Share

15.083

Quarterly Revenue Growth

0.022

Return On Assets

(0.06)

Understanding Tandem Diabetes Care requires distinguishing between market price and book value, where the latter reflects Tandem's accounting equity. The concept of intrinsic value—what Tandem Diabetes' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Tandem Diabetes' price substantially above or below its fundamental value.

Please note, there is a significant difference between Tandem Diabetes' value and its price as these two are different measures arrived at by different means. Investors typically determine if Tandem Diabetes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Tandem Diabetes' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Tandem Interest Income from 2010 to 2026

Latest Tandem Diabetes' Interest Income Growth Pattern

Tandem Interest Income Regression Statistics

Tandem Interest Income History

Other Fundumenentals of Tandem Diabetes Care

Tandem Diabetes Interest Income component correlations

About Tandem Diabetes Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY